Molecular tools are changing how cell-cell communication is read in disease
Cell-cell communication sits at the center of normal biology and disease alike. Growth, differentiation, immune surveillance, and tissue homeostasis all depend on tightly coordinated signals exchanged between neighboring cells, and breakdown in those conversations helps drive cancer, autoimmunity, and neurodegeneration. A 2025 review in National Science Review brings that biology into sharper focus by surveying the molecular technologies now being used to decode multicellular systems with far greater spatial and functional precision than older bulk methods ever allowed.
The central idea is simple, but the technical progress is not. If disease emerges from miswired cellular crosstalk, then the field needs tools that can show who is talking, where the exchange occurs, what molecules are involved, and how those signals alter behavior in real tissue. Super-resolution imaging, proximity labeling, bioorthogonal chemistry, synthetic receptors, and single-cell spatial omics now serve as the main instruments for that task. Each one answers a different layer of the same biological question, and together they are moving the field from broad descriptive biology toward mechanistic medicine.
Super-resolution imaging and proximity labeling expose local signaling with far greater detail
Traditional microscopy often collapses dynamic cellular exchange into a blur of neighboring membranes and indistinct contacts. Super-resolution imaging resolves structures below the diffraction limit of conventional light microscopy, making it possible to examine the physical architecture of cell interfaces and signaling domains with much finer detail. In disease settings where receptor clustering, membrane organization, or immune synapse formation determine downstream function, that extra resolution is not cosmetic; it changes what can be seen and therefore what can be understood.
Proximity labeling brings a different advantage. Instead of relying only on static snapshots, these approaches tag molecules that lie close to a chosen protein or cellular compartment, allowing investigators to identify interaction partners in native biological settings. For cell-cell communication, that means the molecular neighborhood of a receptor, adhesion complex, or secreted factor can be mapped without stripping the system down to an artificial in vitro model. The result is a more realistic view of how signaling circuits assemble in living tissue.
A signaling event is rarely isolated. It is embedded in a local molecular crowd.
Bioorthogonal chemistry extends this strategy by enabling highly specific tagging and tracking of biomolecules without disturbing endogenous chemistry. That precision matters when investigators want to follow glycans, lipids, or newly synthesized molecules across cell boundaries, especially in systems where timing and location determine whether a signal is amplified, buffered, or shut down. For translational work, these methods offer a route to observe disease-relevant communication as it happens rather than reconstructing it after the fact.
Synthetic receptors and spatial omics push the field toward functional medicine
The review gives considerable attention to synthetic receptors, which are designed to sense defined extracellular cues and translate them into programmable intracellular responses. In principle, these constructs do more than reveal a communication pathway; they can intervene in it. That makes them especially relevant for immuno-oncology, where a cell’s ability to recognize the right target, in the right context, can determine whether antitumor activity is unleashed or suppressed. Synthetic receptor systems also point toward cell-based therapies that are more selective and potentially more adaptable than conventional receptor engineering alone.
Single-cell spatial omics adds the tissue map that many previous methods lacked. By preserving where cells are located while measuring molecular signatures at single-cell resolution, spatial omics can connect identity to geography. In cancer, that means distinguishing a tumor cell program from the immune, stromal, or vascular neighborhoods surrounding it. In autoimmune disease, it can reveal how pathogenic cell clusters form and persist. In regenerative medicine, it helps define the local niches that permit repair, differentiation, or failure of regeneration.
This spatial dimension is crucial because multicellular systems do not function as loose collections of cells. They behave as organized ecosystems in which molecular gradients, cell adjacency, and tissue architecture shape every major outcome. A pathway that appears modest in a dissociated-cell experiment may become decisive once the same cells are viewed in their native tissue environment.
Why these tools matter for immuno-oncology, autoimmunity, and regeneration
The translational promise of these technologies is most visible in three broad domains. In immuno-oncology, the challenge is not simply to identify immune cells, but to determine how tumors evade them, how suppressive niches form, and how beneficial interactions can be restored. Tools that define contact zones, secreted mediators, and receptor engagement may help explain why some tumors resist immune attack even when immune cells are present.
In autoimmune disease, the problem runs in the opposite direction: immune signaling becomes excessive, misdirected, or chronically sustained. Spatial and molecular profiling can help pinpoint where aberrant communication begins and which cell populations maintain the inflammatory loop. That kind of mapping is especially important for disorders in which bulk assays miss rare but clinically relevant cellular populations.
Regenerative medicine depends on a different balance. Repair requires the right signals at the right time, from the right cellular neighbors. If those cues are absent or distorted, tissues fail to regenerate properly or heal in a disorganized manner. Molecular tools that define signaling niches may therefore help identify why some tissues regenerate efficiently while others scar, stall, or remain dysfunctional.
Precision medicine will depend on targeting communication itself
The review argues for a future precision medicine framework centered on targeted modulation of cell-cell interactions. That concept shifts therapeutic thinking away from simply suppressing symptoms or broadly blocking a pathway. It instead treats communication itself as a druggable object: a receptor-ligand pair, a synaptic interface, a spatial niche, or a molecular circuit that can be redirected.
This approach is attractive because many diseases are not caused by a single autonomous cellular defect. They emerge from systems-level failures in how cells sense, interpret, and respond to their environment. A drug that restores beneficial communication may be more durable than one that merely blocks a downstream consequence. The tools summarized in this review are not therapies by themselves, but they are the infrastructure needed to design therapies with better biological precision.
The main challenge ahead is integration. Imaging, labeling, chemistry, receptor engineering, and spatial omics each illuminate a different layer of multicellular behavior, but none is sufficient alone. The field now needs methods that can connect structure, molecular identity, and function in one coherent framework, while preserving the tissue context that gives cell-cell communication its meaning. Without that synthesis, the biological conversation remains partially translated. With it, the route from mechanism to medicine becomes much more direct.